Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens

被引:6
作者
Chambers, Christina D. [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Pediat, Div Dysmorphol & Teratol, La Jolla, CA 92093 USA
关键词
cohort study; human teratogen; minor defect; physical examination; RETINOIC ACID EMBRYOPATHY; BIRTH OUTCOMES; CONGENITAL-MALFORMATIONS; EARLY-PREGNANCY; WOMEN; CHILDREN; RISK;
D O I
10.1111/j.1741-4520.2010.00310.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Most known human teratogens are associated with a unique or characteristic pattern of major and minor malformations and this pattern helps to establish the causal link between the teratogenic exposure and the outcome. Although traditional case-control and cohort study designs can help identify potential teratogens, there is an important role for small cohort studies that include a dysmorphological examination of exposed and unexposed infants for minor structural defects. In combination with other study design approaches, the small cohort study with a specialized physical examination fulfills a necessary function in screening for new potential teratogens and can help to better delineate the spectrum and magnitude of risk for known teratogens.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 17 条
  • [1] Maternal Corticosteroid Use and Hypospadias
    Carmichael, Suzan L.
    Ma, Chen
    Werler, Martha M.
    Olney, Richard S.
    Shaw, Gary M.
    [J]. JOURNAL OF PEDIATRICS, 2009, 155 (01) : 39 - 44
  • [2] Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy
    Casper, RC
    Fleisher, BE
    Lee-Ancajas, JC
    Gilles, A
    Gaylor, E
    DeBattista, A
    Hoyme, HE
    [J]. JOURNAL OF PEDIATRICS, 2003, 142 (04) : 402 - 408
  • [3] Birth outcomes in pregnant women taking fluoxetine
    Chambers, CD
    Johnson, KA
    Dick, LM
    Felix, RJ
    Jones, KL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1010 - 1015
  • [4] Chambers CD, 1998, TERATOLOGY, V58, P251, DOI 10.1002/(SICI)1096-9926(199812)58:6<251::AID-TERA6>3.0.CO
  • [5] 2-L
  • [6] Postmarketing surveillance for human teratogenicity: A model approach
    Chambers, CD
    Braddock, SR
    Briggs, GG
    Einarson, A
    Johnson, YR
    Miller, RK
    Polifka, JE
    Robinson, LK
    Stepanuk, K
    Jones, KL
    [J]. TERATOLOGY, 2001, 64 (05) : 252 - 261
  • [7] Birth Outcomes in Women Who Have Taken Leflunomide During Pregnancy
    Chambers, Christina D.
    Johnson, Diana L.
    Robinson, Luther K.
    Braddock, Stephen R.
    Xu, Ronghui
    Lopez-Jimenez, Janina
    Mirrasoul, Nicole
    Salas, Elizabeth
    Luo, Yunjun J.
    Jin, Shelia
    Jones, Kenneth Lyons
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (05): : 1494 - 1503
  • [8] Folic acid antagonists during pregnancy and the risk of birth defects
    Hernández-Díaz, S
    Werler, MM
    Walker, AM
    Mitchell, AA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) : 1608 - 1614
  • [9] The AED (Antiepileptic drug) pregnancy registry - A 6-year experience
    Holmes, LB
    Wyszynski, DF
    Lieberman, E
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (05) : 673 - 678
  • [10] Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations.
    Jentink, Janneke
    Loane, Maria A.
    Dolk, Helen
    Barisic, Ingeborg
    Garne, Ester
    Morris, Joan K.
    de Jong-van den Berg, Lolkje T. W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (23) : 2185 - 2193